Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Medicine Springer Nature Link The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The peptide problem: Hype is outrunning the evidence The "Body Protection Compound": A Deep Dive into BPC 157 DiFrancesco Plastic Surgery BPC 157: Prohibited peptide and unapproved drug in supplements